JoVE - Journal of Visualized Experiments
JoVE Visualize
Contact Us

Contribution of small airway inflammation to the development of COPD

  • 0Department of Pulmonary and Critical Care Medicine, Zhongshan Hospital, Fudan University, 180 Feng Lin Road, Shanghai, 200032, China.
Bmc Pulmonary Medicine +

|

March 5, 2024

|

March 5, 2024

View abstract on PubMed

Summary

This summary is machine-generated.

Small airway inflammation (SAI) is a significant risk factor for developing chronic obstructive pulmonary disease (COPD). Exhaled nitric oxide measurements, particularly FeNO200, effectively predict this inflammation and COPD development.

Area Of Science

  • Pulmonary Medicine
  • Respiratory Research
  • Inflammation Biology

Background

  • Chronic obstructive pulmonary disease (COPD) pathophysiology, especially small airway changes, remains under-investigated.
  • Small airway inflammation (SAI) is visualized via thoracic micro-computed tomography, prompting investigation into its role in COPD development.

Purpose Of The Study

  • To investigate small airway inflammation (SAI) as a risk factor for the development of chronic obstructive pulmonary disease (COPD).
  • To evaluate exhaled nitric oxide (NO) parameters as predictors of peripheral airway/alveolar inflammation in COPD.

Main Methods

  • 1062 patients were analyzed, assessing partitioned airway inflammation using exhaled NO: fractional exhaled NO (FnNO), FeNO50, FeNO200, and calculated CaNOdual.
  • FeNO200 and CaNOdual were compared as predictors of peripheral airway/alveolar inflammation.
  • Correlation between exhaled NO and white blood cell classification identified inflammation types in COPD development.

Main Results

  • Exhaled NO levels (FnNO, FeNO50, FeNO200, CaNOdual) were highest in the COPD group and elevated in emphysema, chronic bronchitis, and smoking groups compared to controls.
  • FeNO200 demonstrated superior predictive value for peripheral airway/alveolar inflammation (AUC=0.841) compared to CaNOdual (AUC=0.707).
  • FeNO200 was identified as a significant risk factor for COPD development (aOR=2.191), with correlations found between blood eosinophils/basophils and FeNO50/FeNO200.

Conclusions

  • COPD exhibits comprehensive airway inflammation, with SAI identified as the primary risk factor for its development.
  • SAI's link to COPD development may be associated with elevated eosinophil and basophil levels.
  • FeNO200 serves as a promising non-invasive biomarker for predicting SAI and COPD risk.

Keywords:

Related Concept Videos

Chronic Obstructive Pulmonary Disease-II: Pathophysiology 01:20

2.8K

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation

• Inhalation of Irritants: Inhaling irritants, especially cigarette smoke, are primary causes of inflammation in COPD. Other irritants can include...

Chronic Obstructive Pulmonary Disease-I: Introduction 01:20

2.8K

Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.

COPD: Pathogenesis and Clinical Features 01:20

272

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...

Chronic Obstructive Pulmonary Disease 01:22

1.2K

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...

Asthma-II: Pathophysiology and Classification 01:26

2.7K

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:

Initiation of Airway Inflammation:

...

Asthma: Pathogenesis and Management 01:20

396

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.